These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12474638)

  • 1. Hyperuricosuric calcium nephrolithiasis.
    Sorensen CM; Chandhoke PS
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):915-25. PubMed ID: 12474638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the urinary potential of hyperuricosuric patients to retard calcium oxalate precipitation.
    Goldwasser B; Sarig S; Azoury R; Orda S; Boichis H; Wax Y; Many M
    Eur Urol; 1985; 11(1):40-3. PubMed ID: 3987747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricosuric calcium urolithiasis.
    Moe OW; Xu LHR
    J Nephrol; 2018 Apr; 31(2):189-196. PubMed ID: 29368300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J; Zechner O
    Eur Urol; 1988; 15(3-4):227-9. PubMed ID: 3215256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of allopurinol action in calcium oxalate stone formers.
    Tomlinson B; Al-Khader A; Cohen SL; Kasidas GP; Krywawych S; Edgar L; Rose GA
    Proc Eur Dial Transplant Assoc; 1981; 18():556-60. PubMed ID: 6276882
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis.
    Pak CY; Barilla DE; Holt K; Brinkley L; Tolentino R; Zerwekh JE
    Am J Med; 1978 Oct; 65(4):593-9. PubMed ID: 707519
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Adv Exp Med Biol; 1980; 128():439-50. PubMed ID: 7424690
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-uric acid nephrolithiasis.
    Coe FL
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricosuria and calcium nephrolithiasis.
    Coe FL; Parks JH
    Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective therapeutic studies in nephrolithiasis.
    Ackermann DK
    World J Urol; 1997; 15(3):172-5. PubMed ID: 9228724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
    Arowojolu O; Goldfarb DS
    J Nephrol; 2014 Dec; 27(6):601-5. PubMed ID: 24687403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid saturation in calcium nephrolithiasis.
    Coe FL; Strauss AL; Tembe V; Le Dun S
    Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.